Soliqua 100/33 (insulin glargine/lixisenatide) is a prescription drug that’s used to treat type 2 diabetes. Soliqua 100/33 comes as a prefilled single-use pen for injecting the drug under your skin.

GLP-1 agonists mimic the natural hormone glucagon-like peptide-1 (GLP-1), produced in the ... Common side effects include nausea, diarrhea, constipation, vomiting, indigestion, and injection site ...

GLP-1 agonists mimic the natural hormone glucagon-like peptide-1 (GLP-1 ... indigestion, and injection site reactions. For a complete list of side effects, refer to the Zepbound medication ...

This article is not intended to be a substitute for professional medical ... a medication classified as a GLP-1 ...

Is compounded semaglutide effective for weight loss? Here’s the short version: Compounded semaglutide isn’t approved by the ...

Medication is not meant to be used as a substitute ... weekly injection, Mounjaro (tirzepatide). Mounjaro is the only dual-acting glucose-dependent insulinotropic polypeptide (GIP) and glucagon ...

Mounjaro comes as an injection that’s given under your skin ... a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist.

Health experts say popular weight-loss drugs like Ozempic and Wegovy are safe, but the FDA warns counterfeits are becoming more widespread.

Iuliia Burmistrova/Getty Images The use of glucagon-like peptide-1 receptor agonists (GLP-1 agonists) for weight loss has been greatly increasing. Past studies show there are positive and negative ...

GLP-1 (short for glucagon-like peptide-1 ... and citrus if they bother you—especially in the few days following injection. Speak to your health care provider about taking over-the-counter ...